Home › Funds › WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST › ABT

WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST position in ABT

ABBOTT LABORATORIES · Health Care

WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST reported holding 3,125,000 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$308.8M, representing 3.37% of its reported portfolio and ranking #13 among its reported holdings. WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)3.12M sh
Reported value held$308.84M
Portfolio Weight3.37%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST's ABT position evolved

WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST first disclosed a stake in ABT in Q3 2023 at 2,700,000 shares (US$261.5M). The position peaked in Q2 2025 at 3,125,000 shares, worth US$425.0M. Across 13 filings, WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 11 time(s). The most recent filing (Q3 2026) shows 3,125,000 shares valued at US$308.8M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 2.70M $261.50M New
Q4 2023 3.12M $343.97M Add
Q1 2024 3.12M $355.19M Hold
Q2 2024 3.12M $324.72M Hold
Q3 2024 3.12M $356.28M Hold
Q4 2024 3.12M $353.47M Hold
Q1 2025 3.12M $414.53M Hold
Q2 2025 3.12M $425.03M Hold
Q3 2025 3.12M $418.56M Hold
Q4 2025 3.12M $391.53M Hold
Q1 2026 3.12M $320.84M Hold
Q2 2026 3.12M $283.56M Hold
Q3 2026 3.12M $308.84M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 21 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST held ABT?

WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST's current position in ABT?

As of Q3 2026, WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST holds 3.12M shares of ABT (ABBOTT LABORATORIES), valued at $308.84M, representing 3.37% of its reported portfolio and ranking #13.

Has WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST been buying or selling ABT?

In the latest 13F filing (Q3 2026), WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST held unchanged its position in ABT. The position peaked in Q2 2025 at 3.12M shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.